Common uses of Azulfidine EN-tabs include treating ulcerative colitis, rheumatoid arthritis, and juvenile rheumatoid arthritis. The medication works to treat ulcerative colitis by inhibiting the production of inflammatory chemicals in the lining of the colon. It is not entirely clear how it works to treat rheumatoid arthritis, but is believed to decrease inflammation and affect the immune system. "Off-label" uses for the medication include the treatment of Crohn's disease.
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that leads to inflammation and sores in the lining of the large intestine and rectum. It commonly causes abdominal pain (stomach pain), diarrhea, and other symptoms, like rectal bleeding or an extreme urgency to have a bowel movement. At this time, the causes of ulcerative colitis are not fully understood. Although ulcerative colitis complications can be quite severe, there is only one ulcerative colitis cure -- surgery. Other than surgery (see Ulcerative Colitis Surgery), treatment options include the following:
Azulfidine EN-tabs is approved to treat cases of mild to moderately active ulcerative colitis, helping to reduce the symptoms. The medication is also approved to prevent the symptoms of ulcerative colitis from returning in people for whom the condition is in remission. For severe ulcerative colitis, Azulfidine EN-tabs is used along with other medications.